Skip to main content
. 2010 May 10;54(8):3427–3431. doi: 10.1128/AAC.01753-09

TABLE 3.

Systemic adverse events judged by the investigator as related to the study drug in part 2 of the studya

Event No. of occurrences in cohort
Total placebo (n = 6) 500 mg q8h (n = 6) 1,000 mg q8h (n = 6) 1,500 mg q12h (n = 6)
Diarrhea 2
Hypoaesthesia 1
Paraesthesia 1
Flushing 1
a

Multiple doses of CXA-101 or placebo (6 CXA-101, 2 placebo per cohort).